A
Ami Neuberger
Researcher at Rappaport Faculty of Medicine
Publications - 65
Citations - 1608
Ami Neuberger is an academic researcher from Rappaport Faculty of Medicine. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 18, co-authored 60 publications receiving 1140 citations. Previous affiliations of Ami Neuberger include Rambam Health Care Campus.
Papers
More filters
Journal ArticleDOI
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial
Dafna Yahav,Dafna Yahav,Erica Franceschini,Fidi Koppel,Adi Turjeman,Adi Turjeman,Tanya Babich,Tanya Babich,Roni Bitterman,Ami Neuberger,Ami Neuberger,Nesrin Ghanem-Zoubi,Antonella Santoro,Noa Eliakim-Raz,Noa Eliakim-Raz,Barak Pertzov,Tali Steinmetz,Anat Stern,Yaakov Dickstein,Elias Maroun,Hiba Zayyad,Jihad Bishara,Jihad Bishara,Danny Alon,Yonatan Edel,Yonatan Edel,Elad Goldberg,Claudia Venturelli,Cristina Mussini,Leonard Leibovici,Leonard Leibovici,Mical Paul,Mical Paul +32 more
TL;DR: In patients hospitalized with Gram-negative bacteremia achieving clinical stability before day 7, an antibiotic course of 7 days was non-inferior to 14 days, an important antibiotic stewardship intervention.
Journal ArticleDOI
Oral iron supplements for children in malaria‐endemic areas
TL;DR: Evaluating the effects and safety of iron supplementation, with or without folic acid, in children living in areas with hyperendemic or holoendemic malaria transmission concluded that iron treatment does not increase the risk of clinical malaria when regular malaria prevention or management services are provided.
Journal ArticleDOI
Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae
Khetam Hussein,Ayelet Raz-Pasteur,Ayelet Raz-Pasteur,Renato Finkelstein,Renato Finkelstein,Ami Neuberger,Yael Shachor-Meyouhas,Yael Shachor-Meyouhas,Ilana Oren,Ilana Oren,Imad Kassis,Imad Kassis +11 more
TL;DR: Mortality among patients with K. pneumoniae bacteraemia is associated with serious comorbidities, but not with carbapenem resistance, and previous antibiotic exposure is a risk factor for CRKP-BSI.
Journal ArticleDOI
Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial.
Mical Paul,Mical Paul,Jihad Bishara,Dafna Yahav,Elad Goldberg,Ami Neuberger,Nesrin Ghanem-Zoubi,Yaakov Dickstein,William Nseir,Michael Dan,Leonard Leibovici,Leonard Leibovici +11 more
TL;DR: High dose trimethoprim-sulfamethoxazole did not achieve non-inferiority to vancomycin in the treatment of severe MRSA infections, and the difference was particularly marked for patients with bacteraemia.
Journal ArticleDOI
Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: A prospective controlled trial.
Ilana Oren,H. Sprecher,Renato Finkelstein,Renato Finkelstein,Salim Hadad,Ami Neuberger,Keatam Hussein,Ayelet Raz-Pasteur,Noa Lavi,Elias Saad,Israel Henig,Netanel A. Horowitz,Irit Avivi,Irit Avivi,Noam Benyamini,Riva Fineman,Yishai Ofran,Yishai Ofran,Nuhad Haddad,Jacob M. Rowe,Jacob M. Rowe,Tsila Zuckerman,Tsila Zuckerman +22 more
TL;DR: Oral antibiotic treatment with nonabsorbable drugs to which CRE is susceptible appears to be an effective and safe for eradication of CRE colonization and, thereby, may reduce patient- to-patient transmission and incidence of clinical infection with this difficult-to-treat organism.